Viewing Study NCT03085758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-22 @ 4:53 PM
Study NCT ID: NCT03085758
Status: COMPLETED
Last Update Posted: 2024-02-21
First Post: 2017-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB
Sponsor: Adrenomed AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Septic Shock View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Early Septic Shock View